A detailed history of Trilogy Capital Inc. transactions in Medtronic PLC stock. As of the latest transaction made, Trilogy Capital Inc. holds 2,495 shares of MDT stock, worth $192,539. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,495
Previous 2,720 8.27%
Holding current value
$192,539
Previous $224,000 3.13%
% of portfolio
0.01%
Previous 0.01%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

SELL
$82.84 - $88.09 $18,639 - $19,820
-225 Reduced 8.27%
2,495 $217,000
Q4 2023

Jan 11, 2024

BUY
$69.43 - $83.43 $188,849 - $226,929
2,720 New
2,720 $224,000
Q2 2023

Jul 24, 2023

BUY
$79.47 - $91.38 $186,039 - $213,920
2,341 New
2,341 $206,000
Q4 2018

Jan 15, 2019

SELL
$85.8 - $99.49 $15,186 - $17,609
-177 Closed
0 $0
Q3 2018

Oct 31, 2018

BUY
$85.91 - $99.17 $3,350 - $3,867
39 Added 28.26%
177 $17,000
Q2 2018

Aug 20, 2018

BUY
$77.48 - $87.83 $4,261 - $4,830
55 Added 66.27%
138 $12,000
Q1 2018

May 24, 2018

BUY
$76.55 - $87.26 $6,353 - $7,242
83 New
83 $7,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $103B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Trilogy Capital Inc. Portfolio

Follow Trilogy Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trilogy Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Trilogy Capital Inc. with notifications on news.